Streetbeat News

Regulatory

CCJ

NATKY

Cameco (NYSE:CCJ) reported significant growth in 2023 with revenue, gross profit, and net earnings all showing substantial increases from the previous year. The company highlighted the global support for nuclear power and its role in achieving net-zero emissions by 2050. Cameco's performance was boosted by increased sales volumes and prices in uranium and fuel services. However, uncertainties include production issues by Kazatomprom (OTCPK: NATKY) and potential U.S. bans on Russian uranium. Cameco has also entered a strategic acquisition of Westinghouse in partnership with Brookfield (NYSE:BN), expecting significant EBITDA growth.

Portfolio Pulse from Stjepan Kalinic

February 09, 2024 | 5:29 pm

MSOS

MSOX

POTX

THCX

Cannabis ETFs are experiencing dynamic changes due to significant regulatory shifts, notably the Department of Health and Human Services' recommendation to reclassify cannabis, and growing Congressional support. The introduction of swap options for U.S. Multi-State Operators (MSOs) has allowed ETFs like MSOS to navigate federal restrictions, leading to a notable performance disparity among cannabis ETFs. MSOX has seen an 88.4% increase YTD, while THCX and POTX are set to close due to challenges from lacking U.S. MSO swap exposure.

Portfolio Pulse from Patricio Liddle

February 09, 2024 | 5:13 pm

BCS

Barclays PLC (NYSE:BCS) is set to halt direct financing of new oil and gas fields and limit lending to energy companies expanding fossil fuel production. This decision is part of its Transition Finance Framework, aimed at reducing emissions linked to bank lending and promoting greener alternatives. Barclays will also require energy sector corporate clients to present transition or decarbonization plans by January 2025, including methane reduction targets and commitments to end non-essential venting and flaring by 2030.

Portfolio Pulse from Lekha Gupta

February 09, 2024 | 5:09 pm

BKKT

Bakkt Holdings, Inc. (BKKT) has amended its Q3 Form 10-Q to include updates on business descriptions and risk factors, notably a going concern risk. This amendment follows the acquisition of Apex Crypto LLC, now Bakkt Crypto Solutions, LLC. Despite this, Bakkt's management remains confident in the business's future, focusing on client delivery, business objectives, and moving towards profitability.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 4:51 pm

AAPL

GOOGL

META

MSFT

NVDA

QQQ

SPY

TSLA

The Market Clubhouse Morning Memo for February 9th, 2024, provides trading strategies for SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA based on proprietary formulas. It includes specific price levels for potential breakouts or reversals and highlights the importance of the upcoming Seasonal CPI Factor Revisions and a speech from Dallas Fed's Lorie Logan.

Portfolio Pulse from RIPS

February 09, 2024 | 3:13 pm

SPY

The Bureau of Labor Statistics reported that Q4 2023 Consumer Price Index (CPI) inflation adjustments remained steady at 3.3%, with minor month-over-month revisions indicating market stability. The December CPI was slightly adjusted to a 0.2% increase. Analysts anticipate a decrease in the annual headline inflation rate to 3% for January, attributed to lower energy costs. Market probabilities suggest an 80% chance of the Federal Reserve maintaining the current fed funds rate in March, with potential policy easing by May. The SPDR S&P 500 ETF Trust (SPY) reached a record high, touching the 5,000 mark.

Portfolio Pulse from Piero Cingari

February 09, 2024 | 2:03 pm

JOBY

Joby Aviation, Inc. (NYSE:JOBY) has received FAA approval for its propulsion certification plan, a crucial step towards obtaining type certification for its electric air taxi. This approval encompasses all structural, mechanical, and electrical systems, positioning Joby as a leader in the electric air taxi certification process. The company has completed 30 for-credit tests with the FAA in 2023 and recently received its Part 145 Maintenance Certificate, further advancing its path to commercialization. Joby's air taxi aims to offer high-speed, low-noise, and zero-emission passenger service.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 2:01 pm

IRON

Disc Medicine has been granted FDA Orphan Drug Designation for DISC-3405, a treatment for Polycythemia Vera, a type of blood cancer. This designation is significant as it provides benefits such as tax credits, eligibility for market exclusivity, and assistance in the drug development process.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 2:01 pm

AACG

ATA Creativity Global (NASDAQ:AACG), an international educational services company, announced it has regained compliance with Nasdaq's minimum bid price requirement. This was achieved after its American depositary shares maintained a closing bid price of $1.00 or greater for 10 consecutive business days from January 17, 2024, to February 6, 2024.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 1:38 pm

HUMA

Humacyte has announced that the FDA has accepted and granted priority review for its Biologics License Application, which seeks approval for its Human Acellular Vessel. This marks a significant step forward in the regulatory process and could lead to the approval of a novel medical product.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 1:01 pm